Publication

Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Medea Gegia, United States Agency for International DevelopmentMatthew James Magee, Emory UniversityRussell Ryan Kempker, Emory UniversityIagor Kalandadze, Gudushauri National Medical CentreTsira Chakhaia, United States Agency for International DevelopmentJonathan E Golub, Johns Hopkins UniversityHenry Blumberg, Emory University
Language
  • English
Date
  • 2015-06-01
Publisher
  • World Health Organization (WHO): Creative Commons Attribution
Publication Version
Copyright Statement
  • © 2015, World Health Organization. All Rights Reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0042-9686
Volume
  • 93
Issue
  • 6
Start Page
  • 390
End Page
  • 399
Grant/Funding Information
  • This work was supported in part by the Johns Hopkins Institute for Global Tobacco Control; the Bloomberg Initiative to Reduce Tobacco Control; the United States National Institute of Health Fogarty International Center (D43TW007124); United States National Institute of Allergy and Infectious Diseases (K23AI1030344); the Atlanta Clinical and Translational Science Institute (NIH/NCATS UL1TR000454); the Emory Global Health Institute; and the Bloomberg Foundation.
Abstract
  • Objective: To assess the effect of tobacco smoking on the outcome of tuberculosis treatment in Tbilisi, Georgia. Methods: We conducted a prospective cohort study of adults with laboratory-confirmed tuberculosis from May 2011 to November 2013. History of tobacco smoking was collected using a standardized questionnaire adapted from the global adult tobacco survey. We considered tuberculosis therapy to have a poor outcome if participants defaulted, failed treatment or died. We used multivariable regressions to estimate the risk of a poor treatment outcome. Findings: Of the 591 tuberculosis patients enrolled, 188 (31.8%) were past smokers and 271 (45.9%) were current smokers. Ninety (33.2%) of the current smokers and 24 (18.2%) of the participants who had never smoked had previously been treated for tuberculosis (P < 0.01). Treatment outcome data were available for 524 of the participants, of whom 128 (24.4%) – including 80 (32.9%) of the 243 current smokers and 21 (17.2%) of the 122 individuals who had never smoked – had a poor treatment outcome. Compared with those who had never smoked, current smokers had an increased risk of poor treatment outcome (adjusted relative risk, aRR: 1.70; 95% confidence interval, CI: 1.00–2.90). Those who had ceased smoking more than two months before enrolment did not have such an increased risk (aRR: 1.01; 95% CI: 0.51–1.99). Conclusion: There is a high prevalence of smoking among patients with tuberculosis in Georgia and smoking increases the risk of a poor treatment outcome.
Author Notes
Keywords
Research Categories
  • Health Sciences, Epidemiology
  • Health Sciences, Public Health
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items